As recently as a few months ago, a lot of signs about the global pandemic seemed to suggest that the worst of the worst was over, and we could all finally begin to put COVID-19 concerns and commentary in the rear view. As contagious variants of the virus have emerged, however, it has become more […]
Read MoreEver since coronavirus found its way to American shores, a lot of media attention has been given to the Healthcare sector – and especially to the Biotechnology industry, where many of the biggest names across the world have been working hard to develop effective treatments for the disease. Available vaccines are now available for distribution […]
Read MorePlus, Best Buy delivered an earnings beat, top tech executives are expected to meet with President Biden at the White House tomorrow to discuss cybersecurity, and Peloton announced its new Tread treadmill.
Read MorePlus, Target also reported an earnings beat, PayPal and Fiserv are partnering to allow gig workers to get their paychecks directly in Venmo, and Southwest Airlines announced a new employee referral bonus.
Read MorePlus, Home Depot said fewer customers visited its stores in the second quarter, Spirit Airlines said recent disruptions cost it around $50 million in revenue, and Bill Ackman’s SPAC was hit with a lawsuit this morning alleging “staggering compensation” to its sponsors.
Read MorePlus, the FDA authorized COVID-19 booster shots for people with weakened immune systems, Disney delivered an earnings beat, and space company Momentus debuted on the Nasdaq.
Read MorePlus, Apple is reportedly planning to make major camera and video upgrades to its new lineup of iPhones, AMC reported a narrower-than-expected loss, and Robinhood is buying Say Technologies.
Read MorePlus, Virgin Galactic shares are up after the company announced it is reopening ticket sales for its space flights, Novavax said it is delaying submission to the FDA for emergency use authorization for its COVID-19 vaccine until the fourth quarter, and Levi Strauss is breaking into the athletic apparel industry in purchasing Beyond Yoga.
Read MoreIn market terms, one of the natural side effects of the COVID-19 health crisis has been an elevated focus on stocks in the Healthcare sector. That covers a wide range of industries, from health insurance to biopharmaceutical and healthcare equipment and supplies. All of these companies have spent the last year and a half not […]
Read MorePlus, the S&P 500 is hovering near its record ahead of a busy earnings week with some of tech’s biggest names reporting, Bitcoin surged to nearly $39,000 on speculation that Amazon may soon accept cryptocurrencies as payment, and BioNTech said it plans to develop an mRNA vaccine for malaria.
Read MorePlus, Twitter also delivered a beat, Boston Beer cited disappointing demand for its hard seltzer as cause for its earnings results miss, and Alphabet launched a new robotics software startup.
Read MoreBioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other infectious diseases. The company is involved in the developing of FixVac product candidates, including BNT111, which is in Phase I clinical trial for advance melanoma; BNT112 that is in Phase I/IIa trial for prostate cancer; BNT113, which is in Phase I/II trial […]
Read MorePlus, Canada said it will allow cruise ships to operate in its waters beginning on November 1, Moderna is joining the S&P 500 next week, and Lordstown Motors confirmed it is being investigated by the Justice Department.
Read MoreBuy Price: $235.00 or better Sell Signal: TradersPro Sell Signal Moderna, Inc., a biotechnology company, develops therapeutics and vaccines based on messenger RNA for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases. As of March 9, 2021, the company had 13 programs in clinical trials and a total of 24 […]
Read MoreBuy Price: $21.00 or better Sell Price: TradersPro Sell Signal INmune Bio, Inc., a clinical-stage immunotherapy company, focuses on reprogramming the patient’s innate immune system to treat cancer Alzheimer’s disease, and non-alcoholic steatohepatitis. The company intends to develop and commercialize product candidates to treat hematologic malignancies, solid tumors, and chronic inflammation. Its development programs include […]
Read More